After attacks in Israel led by Hamas militants on October 7, 2023, Israel launched a major military campaign in the Gaza Strip that has featured an unprecedented scale of destruction. This has included the use of highly destructive weapons in a densely populated area. Mark-84 bombs (M-84s) are 2000 lb air-dropped explosive munitions with the capacity to damage infrastructure and kill or cause severe injury hundreds of meters away. This study examines the proximity of M-84 bomb detonations to hospital infrastructure in the Gaza Strip. We combined geospatial data on hospital locations across the Gaza Strip with maps of the locations of M-84 bomb craters between October 7 and November 17, 2023, published by CNN and New York Times. We then measured and summarized the proximity of the bomb craters to hospitals across the territory. We identified 592 M-84 bomb craters. Of the 36 hospitals across the Gaza Strip, 25% (n = 9) had at least one bomb crater within the lethal range (360 m) and 83.3% (n = 30) within the infrastructure damage and injury range (800 m) of their facilities. The shortest distance of a bomb crater from a hospital was 14.7 m. Two hospitals had as many as 23 and 21 bomb craters within 800 m of their facilities and one hospital had seven bomb craters within 360 m. Thirty-eight M-84 bombs were detonated within 800 m of hospitals in the Israeli military defined evacuation zone. Given the known blast effect of these M-84 bombs, the impact from the bomb detonations near hospitals likely killed and injured people in and around the hospital area, which could include civilians and hospital staff, and likely damaged hospital infrastructure. The results of this study suggest indiscriminate bombing in dangerous proximities to hospital infrastructure, which is afforded special protection under international humanitarian law (IHL).
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11466298 | PMC |
http://dx.doi.org/10.1371/journal.pgph.0003178 | DOI Listing |
Rheumatol Int
January 2025
Pharmacy, Radboudumc, Nijmegen, NL, Netherlands.
This study investigated severity, course and patterns of fatigue surrounding subcutaneous biological disease-modifying antirheumatic drug (bDMARD) injection in inflammatory rheumatic disease (IRD) patients using ecological momentary assessments and investigated self-reported adverse drug reactions (ADRs). In this prospective cohort study, IRD patients completed fatigue severity numeric rating scales (0-10) in web-based ecological momentary assessments in three waves of five days surrounding bDMARD injection. The course of fatigue was measured by the change in fatigue from pre-dosing to post-dosing scores and was classified as: worsening, improving or no clinically relevant change.
View Article and Find Full Text PDFJ Wound Care
January 2025
Nursing and Health Care, School of Health Sciences, South East Technological University, Waterford City, Ireland.
Objective: Wound management can be costly and challenging to the health services' scarce resources. Information regarding the number of wounds in a community care setting and their associated aetiology will provide nurses and nurse managers with an insight into the specific needs of these clients with wounds and highlight areas where care or services can be improved or further developed. This research aimed to establish the prevalence and aetiology of wounds, the current delivery of wound care, wound documentation and referral pathways in an Irish community care setting.
View Article and Find Full Text PDFBMJ Open Qual
December 2024
School of Medicine, Saint Joseph University School of Medical Science, Beirut, Lebanon.
Objective: The aim of this study is to identify the key barriers that prevent medication administration errors (MAEs) from being reported by nurses in Lebanese hospitals.
Methods: A quantitative cross-sectional study was conducted at Hotel-Dieu de France Hospital using a self-administered questionnaire. A total of 275 responses were recorded and analysed using the IBM SPSS software V.
BMJ Open Gastroenterol
December 2024
Australian Centre for Health Services Innovation, Centre for Healthcare Transformation, School of Public Health and Social Work, Faculty of Health, Queensland University of Technology, Kelvin Grove, Queensland, Australia
Objective: Non-alcoholic fatty liver disease (NAFLD) is estimated to affect a third of Australian adults, and its prevalence is predicted to rise, increasing the burden on the healthcare system. The LOCal Assessment and Triage Evaluation of Non-Alcoholic Fatty Liver Disease (LOCATE-NAFLD) trialled a community-based fibrosis assessment service using FibroScan to reduce the time to diagnosis of high-risk NAFLD and improve patient outcomes.
Methods: We conducted a 1:1 parallel randomised trial to compare two alternative models of care for NAFLD diagnosis and assessment.
BMJ Open Gastroenterol
December 2024
Division of Gastroenterology & Hepatology, Weill Cornell Medicine, New York, New York, USA
Objective: Globally, over 50% of the population is affected by , yet research on its prevalence and impact in patients with obesity undergoing laparoscopic sleeve gastrectomy (LSG) is inconclusive. This study aimed to assess the prevalence of infection in individuals with obesity undergoing LSG, evaluate the percentage of postoperative staple-line leaks, and explore the potential link between infection and staple-line leaks.
Methods: This retrospective analysis assessed adult patients with class III obesity who underwent LSG between 2015 and 2020 at a tertiary care hospital in Riyadh, Saudi Arabia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!